Combined Company Expected to be Listed on NASDAQ Global Market DRC Medicine Ltd. (“DRC Medicine” or the “Company”), is an innovative healthcare and biotechnology company headquartered in Japan, ...

The FDA's breakthrough devices program helps the industry with faster review times, but the benefit to patients is unclear.

Around the world, some 16 billion plastic syringes and 15 billion face masks are thrown away each year.1,2 Unknown in the first half of the 20th century, the global production, circulation, and ...

As the world of transfusion medicine evolves, so too does the complexity and capability of blood grouping and typing ...

The medical grade coatings market has traditionally revolved around solutions that improve the performance and biocompatibility of devices used in clinical environments. These coatings, which range ...

Learn how in vitro diagnostic (IVD) devices can comply with IVDR and Indian MDR standards, ensuring regulatory alignment, ...

With the registration, the analyzer can be used for clinical testing in South Korea, expanding Quanterix's reach in that country's in vitro diagnostic and clinical laboratory markets.

The medical device company plans to hire about 200 people over the next three years at the Jersey City facility.

A summary of preclinical evaluation methods for neuroendovascular devices, including in vitro techniques, 3D-printed vascular models, in silico simulations, and in vivo models.

The global In-Vitro Diagnostics (IVDs) Medical Device Market was valued at approximately USD 86 billion in 2024 and is projected to reach USD 135 billion by 2034, growing at a CAGR of 4.8% over ...